ElevateBio attracts $170m Series B
Cambridge, Massachusetts-based ElevateBio LLC, a cell and gene therapy company, has secured $170 million in Series B funding.
Cambridge, Massachusetts-based ElevateBio LLC, a cell and gene therapy company, has secured $170 million in Series B funding.
Copyright PEI Media
Not for publication, email or dissemination
